Can Traws Pharma turn hantavirus urgency into a credible antiviral program?
Hantavirus has no specific antiviral option. Traws Pharma’s next test is turning outbreak urgency into credible clinical candidates.
Can Evommune turn EVO756 into a cross-indication inflammatory franchise with migraine next?
Evommune is taking EVO756 into migraine prophylaxis. Read why MRGPRX2 inhibition could matter, and what risks still cloud the story.